This Indefinite Delivery Contract (IDC) was awarded by the VA National Acquisition Center to Avkare, LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The contract has a ceiling value of $1,244,773.20 and a performance period from July 15, 2024 to July 14, 2025, with four one-year option periods.
The contract aims to provide a wide range of pharmaceutical and medical products to support the healthcare missions of the Department of Veterans Affairs (VA), Department of Defense (DoD), Indian Health Service (IHS), and Bureau of Prisons (BOP). Key items to be delivered include various generic medications like cephalexin capsules, emtricitabine-tenofovir tablets, and prednisone, as well as medical supplies such as lubricant eye drops and lidocaine patches. The procurement was not set-aside and was competed on an unrestricted basis. The contract will be administered through the VA and DoD pharmaceutical prime vendor programs, allowing the government to efficiently order and receive these critical healthcare items on an as-needed basis.
Generated 12/31/24, 2:05 PM